Source: BioSpace

Cytek: Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022

Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 10th, 2022.

Read full article »
Annual Revenue
$164M
Employees
500
Wenbin Jiang's photo - Co-Founder & CEO of Cytek

Co-Founder & CEO

Wenbin Jiang

CEO Approval Rating

81/100

Read more